位置:首页 > 蛋白库 > TPD53_HUMAN
TPD53_HUMAN
ID   TPD53_HUMAN             Reviewed;         204 AA.
AC   Q16890; A8K757; A8K772; A8MUD2; A8MUJ7; A8MW70; F6V707; O43397; Q5TC99;
AC   Q5TDQ0; Q9BUQ6; Q9C054;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   03-AUG-2022, entry version 166.
DE   RecName: Full=Tumor protein D53;
DE            Short=hD53;
DE   AltName: Full=Tumor protein D52-like 1;
GN   Name=TPD52L1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Mammary carcinoma;
RX   PubMed=8812487; DOI=10.1006/geno.1996.0393;
RA   Byrne J.A., Mattei M.-G., Basset P.;
RT   "Definition of the tumor protein D52 (TPD52) gene family through cloning of
RT   D52 homologues in human (hD53) and mouse (mD52).";
RL   Genomics 35:523-532(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), SELF-ASSOCIATION, AND INTERACTION
RP   WITH TPD52 AND TPD52L2.
RX   PubMed=9484778; DOI=10.1038/sj.onc.1201604;
RA   Byrne J.A., Nourse C.R., Basset P., Gunning P.;
RT   "Identification of homo- and heteromeric interactions between members of
RT   the breast carcinoma-associated D52 protein family using the yeast two-
RT   hybrid system.";
RL   Oncogene 16:873-881(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RA   Cho S., Kim J., Ryu S.E.;
RL   Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-86; SER-122; SER-131; SER-149
RP   AND SER-174, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29 AND THR-146, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-133, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- SUBUNIT: Forms a homodimer or heterodimer with other members of the
CC       family.
CC   -!- INTERACTION:
CC       Q16890; P55327: TPD52; NbExp=3; IntAct=EBI-717470, EBI-782581;
CC       Q16890; Q16890: TPD52L1; NbExp=4; IntAct=EBI-717470, EBI-717470;
CC       Q16890; Q62393: Tpd52; Xeno; NbExp=3; IntAct=EBI-717470, EBI-782591;
CC       Q16890-2; Q96AL5: PBX3; NbExp=3; IntAct=EBI-18777952, EBI-741171;
CC       Q16890-2; P55327-2: TPD52; NbExp=3; IntAct=EBI-18777952, EBI-12124194;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q16890-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q16890-2; Sequence=VSP_036754, VSP_036755;
CC       Name=3;
CC         IsoId=Q16890-3; Sequence=VSP_036752, VSP_036753;
CC       Name=4; Synonyms=+5hD53;
CC         IsoId=Q16890-4; Sequence=VSP_036751, VSP_036752, VSP_036753;
CC       Name=5;
CC         IsoId=Q16890-5; Sequence=VSP_036751;
CC   -!- SIMILARITY: Belongs to the TPD52 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC98475.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U44427; AAB40894.1; -; mRNA.
DR   EMBL; U44428; AAB40895.1; -; mRNA.
DR   EMBL; AF004427; AAC98475.1; ALT_INIT; mRNA.
DR   EMBL; AF208012; AAG49634.1; -; mRNA.
DR   EMBL; AK291866; BAF84555.1; -; mRNA.
DR   EMBL; AK291872; BAF84561.1; -; mRNA.
DR   EMBL; AK291887; BAF84576.1; -; mRNA.
DR   EMBL; AL121938; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136128; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW48142.1; -; Genomic_DNA.
DR   EMBL; BC002375; AAH02375.1; -; mRNA.
DR   CCDS; CCDS34527.1; -. [Q16890-2]
DR   CCDS; CCDS34528.1; -. [Q16890-3]
DR   CCDS; CCDS43502.1; -. [Q16890-5]
DR   CCDS; CCDS5130.1; -. [Q16890-1]
DR   CCDS; CCDS75514.1; -. [Q16890-4]
DR   RefSeq; NP_001003395.1; NM_001003395.2. [Q16890-5]
DR   RefSeq; NP_001003396.1; NM_001003396.2. [Q16890-2]
DR   RefSeq; NP_001003397.1; NM_001003397.2. [Q16890-3]
DR   RefSeq; NP_003278.1; NM_003287.3. [Q16890-1]
DR   RefSeq; XP_005267179.1; XM_005267122.2. [Q16890-5]
DR   RefSeq; XP_016866729.1; XM_017011240.1. [Q16890-4]
DR   AlphaFoldDB; Q16890; -.
DR   SMR; Q16890; -.
DR   BioGRID; 113017; 34.
DR   IntAct; Q16890; 17.
DR   MINT; Q16890; -.
DR   STRING; 9606.ENSP00000434142; -.
DR   iPTMnet; Q16890; -.
DR   PhosphoSitePlus; Q16890; -.
DR   BioMuta; TPD52L1; -.
DR   DMDM; 12585368; -.
DR   EPD; Q16890; -.
DR   jPOST; Q16890; -.
DR   MassIVE; Q16890; -.
DR   MaxQB; Q16890; -.
DR   PaxDb; Q16890; -.
DR   PeptideAtlas; Q16890; -.
DR   PRIDE; Q16890; -.
DR   ProteomicsDB; 28063; -.
DR   ProteomicsDB; 61125; -. [Q16890-1]
DR   ProteomicsDB; 61126; -. [Q16890-2]
DR   ProteomicsDB; 61127; -. [Q16890-3]
DR   ProteomicsDB; 61128; -. [Q16890-4]
DR   TopDownProteomics; Q16890-3; -. [Q16890-3]
DR   Antibodypedia; 32681; 257 antibodies from 35 providers.
DR   DNASU; 7164; -.
DR   Ensembl; ENST00000368388.6; ENSP00000357373.2; ENSG00000111907.21. [Q16890-3]
DR   Ensembl; ENST00000368402.9; ENSP00000357387.5; ENSG00000111907.21. [Q16890-2]
DR   Ensembl; ENST00000392482.6; ENSP00000376273.2; ENSG00000111907.21. [Q16890-4]
DR   Ensembl; ENST00000524679.1; ENSP00000432787.1; ENSG00000111907.21. [Q16890-4]
DR   Ensembl; ENST00000532429.5; ENSP00000435447.1; ENSG00000111907.21. [Q16890-5]
DR   Ensembl; ENST00000534000.6; ENSP00000434142.1; ENSG00000111907.21. [Q16890-1]
DR   Ensembl; ENST00000534199.5; ENSP00000432590.1; ENSG00000111907.21. [Q16890-4]
DR   GeneID; 7164; -.
DR   KEGG; hsa:7164; -.
DR   MANE-Select; ENST00000534000.6; ENSP00000434142.1; NM_003287.4; NP_003278.1.
DR   UCSC; uc003pzu.2; human. [Q16890-1]
DR   CTD; 7164; -.
DR   DisGeNET; 7164; -.
DR   GeneCards; TPD52L1; -.
DR   HGNC; HGNC:12006; TPD52L1.
DR   HPA; ENSG00000111907; Tissue enhanced (adrenal gland, salivary gland).
DR   MIM; 604069; gene.
DR   neXtProt; NX_Q16890; -.
DR   OpenTargets; ENSG00000111907; -.
DR   PharmGKB; PA36687; -.
DR   VEuPathDB; HostDB:ENSG00000111907; -.
DR   eggNOG; KOG4010; Eukaryota.
DR   GeneTree; ENSGT00940000159202; -.
DR   HOGENOM; CLU_080743_0_0_1; -.
DR   InParanoid; Q16890; -.
DR   PhylomeDB; Q16890; -.
DR   TreeFam; TF317562; -.
DR   PathwayCommons; Q16890; -.
DR   Reactome; R-HSA-432722; Golgi Associated Vesicle Biogenesis.
DR   SignaLink; Q16890; -.
DR   BioGRID-ORCS; 7164; 11 hits in 1086 CRISPR screens.
DR   ChiTaRS; TPD52L1; human.
DR   GeneWiki; TPD52L1; -.
DR   GenomeRNAi; 7164; -.
DR   Pharos; Q16890; Tbio.
DR   PRO; PR:Q16890; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q16890; protein.
DR   Bgee; ENSG00000111907; Expressed in parotid gland and 194 other tissues.
DR   ExpressionAtlas; Q16890; baseline and differential.
DR   Genevisible; Q16890; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; IDA:UniProtKB.
DR   GO; GO:2001235; P:positive regulation of apoptotic signaling pathway; IDA:UniProtKB.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB.
DR   GO; GO:0043406; P:positive regulation of MAP kinase activity; IDA:UniProtKB.
DR   InterPro; IPR007327; TPD52.
DR   PANTHER; PTHR19307; PTHR19307; 1.
DR   Pfam; PF04201; TPD52; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Methylation; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..204
FT                   /note="Tumor protein D53"
FT                   /id="PRO_0000185741"
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          22..73
FT                   /evidence="ECO:0000255"
FT   MOD_RES         29
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         86
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         122
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         131
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         133
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         146
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         149
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         174
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..29
FT                   /note="Missing (in isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:9484778"
FT                   /id="VSP_036751"
FT   VAR_SEQ         129..131
FT                   /note="SYS -> RRK (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:9484778, ECO:0000303|Ref.3"
FT                   /id="VSP_036752"
FT   VAR_SEQ         132..204
FT                   /note="Missing (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:9484778, ECO:0000303|Ref.3"
FT                   /id="VSP_036753"
FT   VAR_SEQ         143..144
FT                   /note="NS -> RK (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_036754"
FT   VAR_SEQ         145..204
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_036755"
FT   VARIANT         62
FT                   /note="R -> K (in dbSNP:rs6905231)"
FT                   /id="VAR_034568"
FT   CONFLICT        74
FT                   /note="N -> T (in Ref. 4; BAF84576)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        107
FT                   /note="G -> E (in Ref. 4; BAF84561)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   204 AA;  22449 MW;  6B3C336D5C0653C9 CRC64;
     MEAQAQGLLE TEPLQGTDED AVASADFSSM LSEEEKEELK AELVQLEDEI TTLRQVLSAK
     ERHLVEIKQK LGMNLMNELK QNFSKSWHDM QTTTAYKKTH ETLSHAGQKA TAAFSNVGTA
     ISKKFGDMSY SIRHSISMPA MRNSPTFKSF EERVETTVTS LKTKVGGTNP NGGSFEEVLS
     STAHASAQSL AGGSRRTKEE ELQC
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024